These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34697511)

  • 1. Lateral flow assays (LFA) as an alternative medical diagnosis method for detection of virus species: The intertwine of nanotechnology with sensing strategies.
    Sadeghi P; Sohrabi H; Hejazi M; Jahanban-Esfahlan A; Baradaran B; Tohidast M; Majidi MR; Mokhtarzadeh A; Tavangar SM; de la Guardia M
    Trends Analyt Chem; 2021 Dec; 145():116460. PubMed ID: 34697511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in sensitive surface-enhanced Raman scattering-based lateral flow assay platforms for point-of-care diagnostics of infectious diseases.
    Kim K; Kashefi-Kheyrabadi L; Joung Y; Kim K; Dang H; Chavan SG; Lee MH; Choo J
    Sens Actuators B Chem; 2021 Feb; 329():129214. PubMed ID: 36568647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral flow assays (LFA) for detection of pathogenic bacteria: A small point-of-care platform for diagnosis of human infectious diseases.
    Sohrabi H; Majidi MR; Fakhraei M; Jahanban-Esfahlan A; Hejazi M; Oroojalian F; Baradaran B; Tohidast M; Guardia M; Mokhtarzadeh A
    Talanta; 2022 Jun; 243():123330. PubMed ID: 35272153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lateral flow-based nucleic acid detection of SARS-CoV-2 using enzymatic incorporation of biotin-labeled dUTP for POCT use.
    Agarwal S; Warmt C; Henkel J; Schrick L; Nitsche A; Bier FF
    Anal Bioanal Chem; 2022 Apr; 414(10):3177-3186. PubMed ID: 35044487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateral flow assays for viruses diagnosis: Up-to-date technology and future prospects.
    Ince B; Sezgintürk MK
    Trends Analyt Chem; 2022 Dec; 157():116725. PubMed ID: 35815063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview for the Nanoparticles-Based Quantitative Lateral Flow Assay.
    Wang Z; Zhao J; Xu X; Guo L; Xu L; Sun M; Hu S; Kuang H; Xu C; Li A
    Small Methods; 2022 Jan; 6(1):e2101143. PubMed ID: 35041285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of rapid food safety testing: using lateral flow assay platform to detect foodborne pathogens.
    Younes N; Yassine HM; Kourentzi K; Tang P; Litvinov D; Willson RC; Abu-Raddad LJ; Nasrallah GK
    Crit Rev Food Sci Nutr; 2023 Jun; ():1-23. PubMed ID: 37350754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
    Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
    Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated lateral flow assay for effective DNA amplification and detection at the point of care.
    Choi JR; Hu J; Gong Y; Feng S; Wan Abas WA; Pingguan-Murphy B; Xu F
    Analyst; 2016 May; 141(10):2930-9. PubMed ID: 27010033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical lateral flow assays in early diagnosis of SARS-CoV-2 infection.
    Liang R; Fan A; Wang F; Niu Y
    Anal Sci; 2024 May; ():. PubMed ID: 38758251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QDs-based fluorescent lateral flow assays for Point-of-care testing of insulin.
    Kaur J; Deng F; Morris MJ; Goldys E
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A portable and universal upconversion nanoparticle-based lateral flow assay platform for point-of-care testing.
    Gong Y; Zheng Y; Jin B; You M; Wang J; Li X; Lin M; Xu F; Li F
    Talanta; 2019 Aug; 201():126-133. PubMed ID: 31122402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents.
    Grant BD; Anderson CE; Williford JR; Alonzo LF; Glukhova VA; Boyle DS; Weigl BH; Nichols KP
    Anal Chem; 2020 Aug; 92(16):11305-11309. PubMed ID: 32605363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateral flow assays for detection of disease biomarkers.
    Gumus E; Bingol H; Zor E
    J Pharm Biomed Anal; 2023 Feb; 225():115206. PubMed ID: 36586382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equipment-free, salt-mediated immobilization of nucleic acids for nucleic acid lateral flow assays.
    Park JS; Kim S; Han J; Kim JH; Park KS
    Sens Actuators B Chem; 2022 Jan; 351():130975. PubMed ID: 36568876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strip modification and alternative architectures for signal amplification in nanoparticle-based lateral flow assays.
    Díaz-González M; de la Escosura-Muñiz A
    Anal Bioanal Chem; 2021 Jul; 413(16):4111-4117. PubMed ID: 34036400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-Based Lateral Flow Assays: Current Trends in Clinical Diagnostic Rapid Tests.
    Majdinasab M; Badea M; Marty JL
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Silica-Nanomaterial-Assisted Lateral Flow Assay.
    Zhuang H; Xu C; Gao F; Li Y; Lei C; Yu C
    Bioengineering (Basel); 2022 Jun; 9(7):. PubMed ID: 35877318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Progress on Rapid Lateral Flow Assay-Based Early Diagnosis of COVID-19.
    Zhang Y; Chai Y; Hu Z; Xu Z; Li M; Chen X; Yang C; Liu J
    Front Bioeng Biotechnol; 2022; 10():866368. PubMed ID: 35592553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lateral Flow Assay: A Summary of Recent Progress for Improving Assay Performance.
    Omidfar K; Riahi F; Kashanian S
    Biosensors (Basel); 2023 Aug; 13(9):. PubMed ID: 37754072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.